ARUP Laboratories
Castleman Disease Educational Portal
Improving the understanding and diagnosis of Castleman disease through pathology education, tools, and collaboration.
Estimated
4,800
New Castleman cases recorded each year.
Develops before
30 years
Castleman disease usually develops in most patients before reaching 30.
Our mission is to advance the understanding, diagnosis, and treatment of Castleman disease by providing healthcare professionals with
cutting-edge tools, educational resources, and research insights.
Subtypes
UCD & iMCD
UCD affects a single lymph node region, while iMCD affects multiple regions.
Approximately
23-45%
Patients with iMCD die within 5 years of diagnosis.
We strive to bridge knowledge gaps and foster collaboration to improve patient care and
outcomes.